IVERIC bio ISEE
$ 39.95
0.0%
Quarterly report 2023-Q1
added 05-10-2023
IVERIC bio Financial Statements 2011-2024 | ISEE
Annual Financial Statements IVERIC bio
2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
2.97 B | 1.63 B | 455 M | 282 M | 46 M | 109 M | 160 M | 1.87 B | 1.87 B | 281 M | - | - |
Shares |
121 M | 102 M | 74.2 M | 42.2 M | 37.1 M | 35.9 M | 35.5 M | 34.6 M | 33.3 M | 9 M | - | - |
Historical Prices |
24.5 | 16 | 6.14 | 5.43 | 1.42 | 2.71 | 3.58 | 45 | 53.7 | 33.7 | - | - |
Net Income |
-185 M | -115 M | -84.5 M | -58.9 M | 63.1 M | 114 M | -193 M | -106 M | -98.2 M | -51.1 M | -14.6 M | -18.6 M |
Revenue |
- | - | - | - | - | 210 M | 50.9 M | 51.5 M | 41.3 M | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-190 M | -115 M | -88.7 M | -61.3 M | -65.3 M | 108 M | -196 M | -124 M | -80.5 M | -47.4 M | -13.7 M | -19.6 M |
Interest Expense |
62 K | -10 K | -6 K | 151 K | -16 K | -34 K | 34 K | 53 K | - | -1.18 M | - | - |
EBITDA |
-190 M | -115 M | -88.6 M | -61.1 M | -65.2 M | 111 M | -195 M | -123 M | -80.4 M | -47.4 M | -14 M | -19.6 M |
Operating Expenses |
190 M | 115 M | 88.7 M | 61.3 M | 65.3 M | 102 M | 246 M | 175 M | 122 M | 47.4 M | - | - |
General and Administrative Expenses |
72.9 M | 29.7 M | 26 M | 21.6 M | 23.6 M | 35.7 M | 50.2 M | 44 M | 33.4 M | 14.2 M | 6.89 M | 5.74 M |
All numbers in USD currency
Quarterly Income Statement IVERIC bio
2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
137 M | 137 M | 120 M | - | 119 M | 115 M | 105 M | 93.4 M | 93.3 M | 90.1 M | 92.7 M | 57.4 M | 53.4 M | 49.6 M | 41.6 M | 41.5 M | 41.4 M | 41.4 M | 36.2 M | 36.2 M | 36.2 M | 36.1 M | 36 M | 35.9 M | 35.8 M | 35.7 M | 35.6 M | 35.4 M | 35.3 M | 35.2 M | 34.8 M | 34.4 M | 34.2 M | 34 M | 33.5 M | 33.4 M | 32.3 M | 31.4 M | 1.8 M | 1.47 M | 1.47 M | 1.47 M | 1.46 K | - | - | - | - | - | - |
Net Income |
-72.2 M | - | -42.4 M | -49.3 M | -34.5 M | - | -24.6 M | -30.1 M | -26.8 M | -25.4 M | -25.4 M | -18.6 M | -15.1 M | -17.5 M | -14.4 M | -14.4 M | -12.5 M | 104 M | -14.7 M | -13.2 M | -13.1 M | -9.54 M | 189 M | -22.2 M | -43.1 M | -66.3 M | -60.9 M | -29.9 M | -36.3 M | -35.6 M | -39.6 M | -37.1 M | 6.64 M | -31.7 M | 8.55 M | -73 M | -20.7 M | -20.4 M | -16.1 M | -10 M | -4.62 M | -5.61 M | -4.15 M | -5.33 M | -4.76 M | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 207 M | 1.66 M | 1.66 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-73.8 M | - | -42.5 M | - | -34.7 M | - | -24.6 M | -30.2 M | -26.9 M | -25.5 M | -25.5 M | -19 M | -18.7 M | -17.8 M | -15.1 M | -15.2 M | -13.2 M | -21.8 M | -15.4 M | -14.8 M | -13.3 M | -14.9 M | 189 M | -22.5 M | -43.5 M | -67.1 M | -61.2 M | -30.6 M | -36.7 M | -41.2 M | -47.4 M | -42.4 M | 7.54 M | -31.2 M | 13.7 M | -42.3 M | -20.7 M | -20.4 M | -15.3 M | -7.59 M | -4.13 M | -3.55 M | -3.85 M | -3.27 M | -3.01 M | - | - | - | - |
Interest Expense |
-1.85 M | - | -39 K | - | 1 K | - | -10 K | -2 K | -1 K | - | 1 K | -12 K | 5 K | - | - | 151 K | - | - | -1 K | - | -16 K | - | -12 K | -1 K | -21 K | - | -20 K | -98 K | 30 K | - | 19 K | 79 K | -52 K | - | - | - | - | - | - | - | - | - | 230 K | - | - | - | - | - | - |
EBITDA |
-73.8 M | - | -42.4 M | - | -34.6 M | - | -24.6 M | -30.2 M | -26.9 M | -25.5 M | -25.4 M | -18.9 M | -18.7 M | -17.8 M | -14.9 M | -15.1 M | -13.1 M | -21.8 M | -15.3 M | -14.8 M | -13.3 M | -14.9 M | 189 M | -21.9 M | -42.7 M | -67.1 M | -61 M | -30.4 M | -36.6 M | -41.2 M | -47.4 M | -42 M | 7.59 M | -31.2 M | 13.7 M | -42.2 M | -20.7 M | -20.4 M | -15.3 M | -7.58 M | -4.12 M | -3.55 M | -3.83 M | -3.27 M | -3.01 M | - | - | - | - |
Operating Expenses |
73.8 M | - | 42.5 M | - | 34.7 M | - | 24.6 M | 30.2 M | 26.9 M | - | 25.5 M | 19 M | 18.7 M | - | 15.1 M | 15.2 M | 13.2 M | - | 15.4 M | 14.8 M | 13.3 M | - | 17.8 M | 24.2 M | 45.1 M | - | 62.9 M | 58.8 M | 52.5 M | - | 50.9 M | 44 M | 34.1 M | - | 25.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
31.8 M | - | 17.5 M | - | 12.1 M | - | 6.65 M | 6.72 M | 8.32 M | 8.02 M | 6.64 M | 6.29 M | 5 M | 6.28 M | 4.67 M | 5.2 M | 5.48 M | 5.67 M | 5.97 M | 6.33 M | 5.64 M | 6.91 M | 7.06 M | 8.55 M | 13.2 M | 13 M | 12 M | 10.5 M | 14.7 M | 12.1 M | 10.4 M | 12 M | 9.58 M | 10.7 M | 8.81 M | 7.57 M | 6.35 M | 5.06 M | 4.17 M | 3.24 M | 1.74 M | 1.55 M | 2.26 M | 1.69 M | 1.39 M | - | - | - | - |
All numbers in USD currency